Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1985]

Vadastuximab talirine in combination for newly diagnosed AML

Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA

Vadastuximab talirine in combination for newly diagnosed AML ( Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA )

Novel antibody boosts responses in newly diagnosed AML

Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA

Novel antibody boosts responses in newly diagnosed AML ( Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA )

Anti CD22 CAR T cell therapy for relapsed paediatric ALL

Dr Nirali Shah - National Cancer Institute, Bethesda, USA

Anti CD22 CAR T cell therapy for relapsed paediatric ALL ( Dr Nirali Shah - National Cancer Institute, Bethesda, USA )

A new spin on leukaemia therapy

Prof Armand Keating - University of Toronto, Toronto, Canada

A new spin on leukaemia therapy ( Prof Armand Keating - University of Toronto, Toronto, Canada )

Subgroup analysis of elderly high risk AML patients receiving CPX-351

Prof Jeffery Lancet - H. Lee Moffitt Cancer Center, Tampa, USA

Subgroup analysis of elderly high risk AML patients receiving CPX-351 ( Prof Jeffery Lancet - H. Lee Moffitt Cancer Center, Tampa, USA )

Remissions following anti-CD22 CAR therapy in children with relapsed ALL

Dr Terry Fry - National Cancer Institute, Bethesda, USA

Remissions following anti-CD22 CAR therapy in children with relapsed ALL ( Dr Terry Fry - National Cancer Institute, Bethesda, USA )

CPX-351 after stem cell transplant for elderly patients with AML

Prof Jeffery Lancet - H. Lee Moffitt Cancer Center, Tampa, USA

CPX-351 after stem cell transplant for elderly patients with AML ( Prof Jeffery Lancet - H. Lee Moffitt Cancer Center, Tampa, USA )

Involving young people in cancer research

Lorna Fern - Teenage and Young Adult Clinical Studies Group, NCRI, UK

Involving young people in cancer research ( Lorna Fern - Teenage and Young Adult Clinical Studies Group, NCRI, UK )

AML: Is less as good as more?

Dr Rebecca Olin - University of California San Francisco, San Francisco,, USA

AML: Is less as good as more? ( Dr Rebecca Olin - University of California San Francisco, San Francisco,, USA )

The creation of SIOG, and a systematic review of the AML literature

Dr Martine Extermann - Moffitt Cancer Center, Tampa, USA

The creation of SIOG, and a systematic review of the AML literature ( Dr Martine Extermann - Moffitt Cancer Center, Tampa, USA )

Multiple myeloma in the elderly

Prof Tanya Wildes - Washington University School of Medicine, St. Louis, USA

Multiple myeloma in the elderly ( Prof Tanya Wildes - Washington University School of Medicine, St. Louis, USA )

Using adoptive cell therapy to fight cancer

Prof Malcolm Brenner - Baylor College of Medicine, Houston, USA

Using adoptive cell therapy to fight cancer ( Prof Malcolm Brenner - Baylor College of Medicine, Houston, USA )

More from ecancer